Humana Contracts with CleanSlate Centers to Provide Opioid Addiction Services
Sep 27, 2017
New agreement provides Humana Medicare Advantage and employer plan members with access to CleanSlate outpatient treatment centers in eight states
BRENTWOOD, Tenn. and LOUISVILLE, Ky. – September 27, 2017 – CleanSlate Centers and health and well-being company Humana Inc. (NYSE: HUM) have signed a new contract that provides in-network access for Humana Medicare Advantage and employer plan members at CleanSlate outpatient addiction treatment centers.
The agreement provides in-network access for Humana Medicare Advantage Health Maintenance Organization (HMO), Preferred Provider Organization (PPO), and Private Fee-for-Service (PFFS) health plan members and employer plan members seeking treatment at nearly 30 CleanSlate facilities in eight states: Arizona, Connecticut, Florida, Indiana, Massachusetts, Pennsylvania, Texas, and Wisconsin. Using quality, evidence-based practices, CleanSlate provides medication-assisted treatment and related therapies, primarily for alcohol and opioid use disorders.
“Expanding access to addiction treatment services is critical as we strive to remove barriers to care and serve members in need,” said Humana Behavioral Health’s Chief Medical Officer, Dr. Larry Weinstein. “We are pleased to work with CleanSlate in supporting our members as they seek to improve their well-being and lead healthier lives.”
The partnership aligns with Humana’s Bold Goal strategy, a commitment to help make the communities it serves 20 percent healthier by 2020. Through interventions and community partnerships, Bold Goal is addressing some of the country’s most significant conditions and barriers to health, with a particular focus on behavioral health. Humana uses a Health Related Quality of Life (HRQoL) tool, known as Healthy Days, to benchmark community health and measure progress. The tool, developed by the U.S. Centers for Disease Control and Prevention (CDC), takes into account how a person is feeling both physically and mentally.
According to the American Society of Addiction Medicine (ASAM), addiction to opioids – including to prescription pain relievers and heroin – is defined as a primary, chronic, and relapsing brain disease. Opioids killed more than 33,000 Americans in 2015. Drug overdose is now the leading cause of accidental death among Americans, with a greater number of annual related fatalities than those from car accidents and firearms, according to the Drug Enforcement Agency.
“At CleanSlate, we’ve made it our mission to expand access to life-saving treatment to help patients achieve the lives they want and deserve,” said Gregory Marotta, president and CEO of CleanSlate Centers. “We know that the best way to fight the addiction epidemic is by working together, and we are thrilled to now offer our services to Humana members in communities across the country.”
Terms of the agreement were not disclosed.
About CleanSlate Centers
A pioneer and leader in outpatient addiction medicine, CleanSlate Centers is a national medical group which provides treatment for the chronic disease of addiction, primarily opioid and alcohol use disorders. Founded in 2009 in response to the growing opioid epidemic facing the country, the company is a growing, multi-state network of physician-led outpatient addiction treatment centers where patients who have addiction and associated disorders can receive medication-assisted treatment and related therapies using the highest quality, evidence-based practices.
Using the latest science- and medicine-based treatment guidelines, CleanSlate is bringing effective outpatient treatment to tens of thousands of new patients across the country. The company has provided treatment to nearly 20,000 patients.
In 2014, CleanSlate partnered with Apple Tree Partners, a growth equity fund, to help expand efforts geographically and increase access to care in underserved communities with demonstrated need. For a list of participating CleanSlate facilities, visit https://www.cleanslatecenters.com/our-location.
Humana Inc. (NYSE: HUM) is committed to helping our millions of medical and specialty members achieve their best health. Our successful history in care delivery and health plan administration is helping us create a new kind of integrated care with the power to improve health and well-being and lower costs. Our efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large.
To accomplish that, we support physicians and other health care professionals as they work to deliver the right care in the right place for their patients, our members. Our range of clinical capabilities, resources and tools – such as in-home care, behavioral health, pharmacy services, data analytics and wellness solutions – combine to produce a simplified experience that makes health care easier to navigate and more effective.
More information regarding Humana is available to investors via the Investor Relations page of the company’s web site at www.humana.com, including copies of:
- Annual reports to stockholders
- Securities and Exchange Commission filings
- Most recent investor conference presentations
- Quarterly earnings news releases and conference calls
- Calendar of events
- Corporate Governance information
Humana is a Medicare Advantage HMO, PPO, and PFFS organization with a Medicare contract. Enrollment in any Humana Medicare plan depends on contract renewal. Other providers are available in our network. The provider network may change at any time. You will receive notice when necessary.
FOR MORE INFORMATION, CONTACT:
Humana Corporate Communications